DoseMate Pro
GLP-1 Shot & Weight Tracker
$2.99 · Designed for iPad. Not verified for macOS.
Track GLP-1 injections with ease. Built by real users for Ozempic, Wegovy, Mounjaro, and Zepbound. Log doses, weight, and side effects in one simple app.
Track Your GLP-1 Journey with Confidence
DoseMate Pro is the simple, intuitive medication tracker designed by actual GLP-1 users for people taking Ozempic, Wegovy, Mounjaro, Zepbound, and other GLP-1 medications. Whether you are managing type 2 diabetes or on a weight loss journey, DoseMate helps you stay on track with your treatment.
Built by Users, for Users
Unlike other apps built by developers who have never taken these medications, DoseMate was created by people who understand the real challenges of GLP-1 therapy. We know what matters because we live it every day.
KEY FEATURES
INJECTION TRACKING
- Log each injection with date, time, and dosage
- Track injection site rotation to prevent skin irritation
- View complete injection history at a glance
- Smart countdown to your next scheduled dose
WEIGHT MONITORING
- Track your weight progress over time
- See trends with beautiful, easy-to-read charts
- Monitor weight changes alongside your treatment
- Support for both pounds and kilograms
SIDE EFFECT LOGGING
- Record side effects and symptoms
- Track severity and duration
- Identify patterns between doses and symptoms
- Share insights with your healthcare provider
SMART REMINDERS
- Customizable injection reminders
- Never miss a dose with timely notifications
- Flexible scheduling for weekly injections
APPLE HEALTH INTEGRATION
- Sync weight data automatically with Apple Health
- View all your health metrics in one place
- Secure and private data storage on your device
DOCTOR REPORTS
- Export comprehensive PDF summaries
- Share your progress with healthcare providers
- Include injection history, weight trends, and side effects
WHY CHOOSE DOSEMATE?
NO SUBSCRIPTION REQUIRED
Unlike other GLP-1 tracker apps that charge monthly fees, DoseMate offers lifetime access with a single purchase. No recurring payments, no hidden costs.
SIMPLE AND INTUITIVE
Clean, modern design that anyone can use. No complicated menus or confusing features. Just open the app and start tracking.
PRIVACY FIRST
Your health data stays on your device. We never sell your information or share it with third parties.
SUPPORTED MEDICATIONS
- Ozempic (semaglutide)
- Wegovy (semaglutide)
- Mounjaro (tirzepatide)
- Zepbound (tirzepatide)
- Rybelsus (semaglutide)
- Saxenda (liraglutide)
- Victoza (liraglutide)
- Trulicity (dulaglutide)
- Other GLP-1 receptor agonists
PERFECT FOR
- People starting GLP-1 therapy
- Weight management patients
- Type 2 diabetes management
- Anyone wanting to track their injection schedule
IMPORTANT HEALTH DISCLAIMER
DoseMate is designed for tracking and educational purposes only. It is not intended to provide medical advice, diagnosis, or treatment. Always consult with your healthcare provider for any medical decisions or concerns about your GLP-1 medication.
START TRACKING TODAY
Download DoseMate and take control of your GLP-1 journey. Join thousands of users who trust DoseMate to manage their medication schedule, track their progress, and stay on top of their health goals.
Ratings & Reviews
- This app hasn’t received enough ratings or reviews to display an overview.
The developer, 贺 周, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Not Collected
The developer does not collect any data from this app.
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- 贺 周
- Size
- 2.3 MB
- Category
- Health & Fitness
- Compatibility
Requires iOS 18.4 or later.
- iPhone
Requires iOS 18.4 or later. - iPad
Requires iPadOS 18.4 or later. - Mac
Requires macOS 15.4 or later and a Mac with Apple M1 chip or later. - Apple Vision
Requires visionOS 2.4 or later.
- iPhone
- Languages
- English
- Age Rating
9+
- 9+
- Copyright
- © 202603160937
